학술논문

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Document Type
article
Author
Sawhney, Jitendra PSKothiwale, Veerappa ABisne, VikasDurgaprasad, RajashekharJadhav, PraveenChopda, ManojVanajakshamma, VelamMeena, RamdhanVijayaraghavan, GovindanChawla, KamaldeepAllu, JaganPieper, Karen SCamm, A JohnKakkar, Ajay KBassand, Jean-PierreFitzmaurice, David AGoldhaber, Samuel ZGoto, ShinyaHaas, SylviaHacke, WernerMantovani, Lorenzo GMisselwitz, FrankTurpie, Alexander GGvan Eickels, MartinVerheugt, Freek WAKayani, GloriaFox, Keith AAGersh, Bernard JLuciardi, Hector LucasGibbs, HarryBrodmann, MarianneCools, FrankBarretto, Antonio Carlos PereiraConnolly, Stuart JSpyropoulos, AlexEikelboom, JohnCorbalan, RamonHu, DayiJansky, PetrNielsen, Jørn DalsgaardRagy, HanyRaatikainen, PekkaLe Heuzey, Jean-YvesDarius, HaraldKeltai, MatyasKakkar, SanjaySawhney, Jitendra Pal SinghAgnelli, GiancarloAmbrosio, GiuseppeKoretsune, YukihiroDíaz, Carlos Jerjes SánchezCate, Hugo TenAtar, DanStepinska, JaninaPanchenko, ElizavetaLim, Toon WeiJacobson, BarryOh, SeilViñolas, XavierRosenqvist, MartenSteffel, JanAngchaisuksiri, PantepOto, AliParkhomenko, AlexMahmeed, Wael AlFitzmaurice, DavidHu, DYChen, KNZhao, YSZhang, HQChen, JZCao, SPWang, DWYang, YJLi, WHYin, YHTao, GZYang, PChen, YMHe, SHWang, YingWang, YongFu, GSLi, XWu, TGCheng, XSYan, XWZhao, RPChen, MSXiong, LGChen, P
Source
Indian Heart Journal. 70(6)
Subject
Hematology
Prevention
Cardiovascular
Clinical Research
Heart Disease
6.1 Pharmaceuticals
Evaluation of treatments and therapeutic interventions
Aged
Atrial Fibrillation
Electrocardiography
Female
Follow-Up Studies
Humans
Incidence
India
Male
Prevalence
Prognosis
Prospective Studies
Registries
Risk Assessment
Risk Factors
Survival Rate
Thromboembolism
Time Factors
Anticoagulant therapy
Arrhythmia
Atrial fibrillation
GARFIELD-AF
GARFIELD-AF Investigators
Cardiovascular System & Hematology
Language
Abstract
BackgroundThe Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry.Methods and resultsA total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P